Track & Trace: New Questions and Answers published by the EU
Recommendation
4 June 2025
Vienna, Austria
It was only in June this year when the European Commission published Version 7.0 of their question and answer catalogue on practical implementation and technical aspects of serialisation requirements as per delegated act EU 2016/161. The follow-up version 8.0 was published on November 22, 2017, already. It includes 72 questions and answers in ten chapters, meaning that it has once more been expanded by important questions and an additional chapter.
The changes compared to the previous version 7.0 are as follows:
- Q&As 1.17, 1.18, 7.13, 7.14, 7.15, 8.4 and 10.1 have been added;
- Q&As 1.2, 2.12 and 3.3 have been revised.
Amongst others, there are new detailed explanations on the requirements parallel importers have to meet as well as answers to the question what exactly is meant by release for sale and distribution, also considering the last putting into circulation of drug products without safety features.
Finally, known positions regarding the (non-) applicability of requirements to radiopharmaceuticals and vaccines are explicitly addressed, as well.
Overall, the complexity of the policy is revealed as well as the challenges of practical implementation and the need for answers to specific questions.
Version 8.0 of the Q&A for EU FMD DR regarding serialisation can be viewed here.
Related GMP News
31.07.2024Report on Trends in the Falsification of Medicines
11.06.2024Serialization - Version 21 of the Q&As on Safety Features
17.01.2024Ozempic Falsification also in the US
20.12.2023US Track & Trace Guidance on Verification Systems
07.12.2023Falsification of Ozempic Confirmed
18.10.2023Ozempic Falsifications: BfArM starts Investigation